Complear

⛑ 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽: 𝗜𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗔𝗜 𝗔𝗰𝘁 & 𝗚𝗹𝗼𝗯𝗮𝗹 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲 𝗼𝗳 𝗔𝗜 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 Join us for an insightful workshop at the 𝟰𝘁𝗵 𝗗𝗶𝗴𝗶𝘁𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗟𝗶𝘀𝗯𝗼𝗻 led by Miguel Amador, Chief Innovation Officer at Complear, on the Implementation of the AI Act & Global Perspective of AI Regulation. This essential session will delve into the profound implications of the AI Act for the healthcare sector, offering a comprehensive overview of global regulatory trends and practical guidance for pharmaceutical companies and healthcare providers. Why Attend? 💡 Overview of the AI Act: Learn about key provisions and requirements relevant to healthcare and pharmaceuticals, and how they impact your organization. 💡Global AI Regulatory Landscape: Discover how international AI regulations and standards compare with the AI Act. 💡Impact on Healthcare: Understand the influence of the AI Act on industry usage, data privacy, and ethical considerations. 💡Implementation Roadmap: Gain industry-specific guidance for integrating AI within your business activities seamlessly. 💡Case Studies: Explore real-world examples of AI implementation in healthcare and its regulatory implications. 💡Q&A Session: Engage directly with experts to address your specific concerns and questions. 📅 Don't miss this opportunity to stay ahead in the rapidly changing world of AI in healthcare. Register here https://lnkd.in/dnGCCigv At the 4th Digital Health Conference in Lisbon, you will learn from speakers: 🎤 Ghaith Sankari, Head of Global Digital Health Data Science, Bayer 🎤 Paula Salme Sandrak, Product Strategist (dHealth & Health AI), Bayer 🎤 Dr. Ricardo Sáinz Fuertes, Global Director Digital Health Solutions NEURii Program Director, Eisai EMEA 🎤 Sridevi Nagarajan, Head Digital Regulatory Strategy, AstraZeneca 🎤 Lu Zheng, Head of Value-Based Partnerships and Digital Health, Europe & Canada, Takeda 🎤 Dan Ma, Head of Innovation & New Commercial Partnerships, Sandoz 🎤 Ayaka Yanagisawa, Former Head of Data Analytics, Biogen 🎤 Gemma Malla Salomó, Head of Digital Medicines Iberia & Business Unit Head Ophthalmology, Angelini Pharma 🎤 Leslie Anne Fendt, Global digital health program lead, myVisionTrack Roche 🎤 Pete Brockmeier, Global Associate Director, Digital Health, Novo Nordisk 🎤 Miguel Amador, Partner and Chief Innovation Officer, Complear 🎤 Charlotte S., Senior Digital Health Scientist, Lundbeck 🎤Julia Chernova, Associate Director, Clinical Statistics and Digital Health, Bayer 🎤Katherine Ossenkopp, Country Manager Germany, Future4Care and others... #AIRegulation #HealthcareInnovation #AIAct #DigitalHealth #Pharmaceuticals #GlobalPerspective #Compliance #Innovation #Complear #MiguelAmador #AIInHealthcare #AIRegulationWorkshop

[PT] 🔎 Conheça os serviços prestados pela TB4Health. 👉A TB4Health disponibiliza serviços de desenvolvimento, teste e experimentação de novos produtos ou serviços digitais das PME e start-ups do setor da saúde. 🌐 Para conhecer em detalhe estes serviços, visite o nosso website: www.tb4health.pt/servicos [EN] 🔎 Find out more about the services provided by TB4Health.  👉TB4Health offers development, testing and experimentation services for new digital products or services for SMEs and start-ups in the health sector.  🌐 More info: https://lnkd.in/dxbRT8Qg Complear Medtronic ULS de Coimbra ULS Santa Maria Lusíadas Saúde #tb4health #testbed #inovacao #tecnologia #startup #pme #digitalinnovation #inovacao #redenacionaldetestbeds #biocantpark #complear #medtronic #ulssantamaria #ulscoimbra #lusiadassaude

Today we are celebrating the first wave of 55 new Pledgers who have joined the EIT Deep Tech Talent Initiative since April 2024! 🚀 With a grand total of 220 new Pledgers since April, we'll showcase more organisations in the coming weeks. We're excited to collaborate with these innovative organisations and drive the future of deep tech together. ➡️ Discover our Pledger community! https://bit.ly/49nenF9 #EITDeepTechTalent

AI as medical devices. The potential of this technology is immense. Regulation should not delay innovation, but rather ensure the safety and effectiveness of AI systems where they will have the greatest impact: in clinical practice. Therefore, clinical assessment is crucial. Hospitals and other healthcare services need to comply with clinical performance regulatory requirements to ensure the best outcomes for patients. Complear exists to help on this path. As I often say, in addition to being AI, these tools are medical devices. I thank UpHill Health for the opportunity to discuss this very relevant topic and my colleagues on the panel for their excellent insights. This debate is just beginning. Cláudia Furtado, Adolfo Mesquita Nunes, Madureira Mariana Duarte Sequeira, Eduardo Freire Rodrigues

⌛ Only one day left until we kick off the Patient Journey Summit, and we are thrilled to present another panel of experts. Care journeys are increasingly managed by technological platforms and AI models, where technology automates processes previously handled by healthcare professionals and transforms care journeys themselves. The benefits of increased capacity and access to healthcare are undeniable, but ethical challenges remain. In this session, we will discuss the regulatory framework of artificial intelligence and medical devices, as well as the gray areas that still exist. Meet our speakers: 👤 Adolfo Mesquita Nunes (Pérez-Llorca) 👤 Daniel A. Dourado (Complear) 👤 Madureira Mariana (INFARMED, I.P.) Moderation will be led by Cláudia Furtado.